Table 2. IPA enrichment analysis of human orthologs for three types of delay relative to mouse/bovine transcripts.
| Delay compared to human | Organism | Pathway (# Transcripts identified/# Transcripts in pathway) | P value |
|---|---|---|---|
| >0 | Mouse | EIF2 Signaling (79/173) | 7.94 × 10−18 |
| mTOR Signaling (71/183) | 5.64 × 10−12 | ||
| Regulation of eIF4 and p70S6K Signaling (60/143) | 5.72 × 10−11 | ||
| Bovine | Protein Ubiquitination Pathway (54/254) | 6.28 × 10−09 | |
| Amyloid Processing (19/50) | 4.36 × 10−08 | ||
| Glucocorticoid Receptor Signaling (51/272) | 1.03 × 10−06 | ||
| 0 | Mouse | Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis (196/286) | 1.84 × 10−31 |
| Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis (149/213) | 6.88 × 10−27 | ||
| Axonal Guidance Signaling (115/157) | 1.29 × 10−22 | ||
| Bovine | Protein Kinase A Signaling (199/370) | 7.11 × 10−16 | |
| Thrombin Signaling (116/187) | 1.44 × 10−15 | ||
| Acute Phase Response Signaling (106/168) | 4.51 × 10−15 | ||
| <0 | Mouse | Ephrin Receptor Signaling (76/172) | 8.39 × 10−13 |
| Molecular Mechanism of Cancer (128/359) | 5.26 × 10−12 | ||
| B Cell Receptor Signaling (71/171) | 1.54 × 10−10 | ||
| Bovine | EIF2 Signaling (91/173) | 1.75 × 10−25 | |
| Regulation of eIF4 (55/143) | 3.48 × 10−09 | ||
| Protein Ubiquitination Pathway (83/254) | 5.11 × 10−09 | ||
| >0, 0, <0 | Mouse, | EIF2 Signaling (32/173) | 1.59 × 10−17 |
| Bovine | Regulation of eIF4 (21/143) | 5.25 × 10−10 | |
| Acetyl-CoA Biosynthesis I (Pyruvate Dehydrogenase Complex) (4/6) | 8.71 × 10−06 |
The top three IPA enriched pathways are listed. Associated transcripts were analysed separately with respect to the delay: positive (negative) delay indicates that the mouse or bovine ortholog’s expression changes occurred prior to (after) the human expression changes. No delay indicates that all expression changes occurred simultaneously. P values were obtained from a right tailed Fisher’s Exact Test as implemented by IPA.